EUVIMEDEUVIMED entdecken
Crossref

Fluoropolymer-MOF Hybrids with Switchable Hydrophilicity for 19 F MRI-Monitored Cancer Therapy

Qiaoyun Wang, Ye Yu, Yixin Chang, Xin Xu, Min Wu, Gayathri R Ediriweera, Hui Peng, Xu Zhen iD, Xiqun Jiang iD, Debra J Searles iD, Changkui Fu iD, Andrew K Whittaker iD

ACS Nano · 09.05.2023 · 17 (9) · 8483-8498

DOI: 10.1021/acsnano.3c00694 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 25.04.2023. Verfasst von Qiaoyun Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, Queensland 4072, Australia. Hauptthemen laut MEDLINE: Metal-Organic Frameworks, Neoplasms, Nanoparticles. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: National Health and Medical Research Council, Australian Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer theranostics that combines cancer diagnosis and therapy is a promising approach for personalized cancer treatment. However, current theranostic strategies suffer from low imaging sensitivity for visualization and an inability to target the diseased tissue site with high specificity, thus hindering their translation to the clinic. In this study, we have developed a tumor microenvironment-responsive hybrid theranostic agent by grafting water-soluble, low-fouling fluoropolymers to pH-responsive zeolitic imidazolate framework-8 (ZIF-8) nanoparticles by surface-initiated RAFT polymerization. The conjugation of the fluoropolymers to ZIF-8 nanoparticles not only allows sensitive in vivo visualization of the nanoparticles by 19F MRI but also significantly prolongs their circulation time in the bloodstream, resulting in improved delivery efficiency to tumor tissue. The ZIF-8-fluoropolymer nanoparticles can respond to the acidic tumor microenvironment, leading to progressive degradation of the nanoparticles and release of zinc ions as well as encapsulated anticancer drugs. The zinc ions released from the ZIF-8 can further coordinate to the fluoropolymers to switch the hydrophilicity and reverse the surface charge of the nanoparticles. This transition in hydrophilicity and surface charge of the polymeric coating can reduce the "stealth-like" nature of the agent and enhance specific uptake by cancer cells. Hence, these hybrid nanoparticles represent intelligent theranostics with highly sensitive imaging capability, significantly prolonged blood circulation time, greatly improved accumulation within the tumor tissue, and enhanced anticancer therapeutic efficiency.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metal-Organic FrameworksNeoplasmsNanoparticlesHumansFluorocarbon PolymersMagnetic Resonance ImagingHydrophobic and Hydrophilic InteractionsZincIonsTumor Microenvironment

Stichwörter der Autor:innen

ZIF-8-PFSAM hybrid nanoparticleslow-foulingmagnetic resonance imagingsulfoxide-containing polymerstheranostics

Substanzen

Fluorocarbon PolymersMetal-Organic FrameworksZincIons

Autor:innen und Institutionen

  • Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, Queensland 4072, Australia.
  • Department of Polymer Science & Engineering, College of Chemistry & Chemical Engineering, Nanjing University, Nanjing 210093, PR China.

ORCID-Profile: Xu Zhen, Xiqun Jiang, Debra J Searles, Changkui Fu, Andrew K Whittaker

Förderung

  • National Health and Medical Research Council
  • Australian Research Council

Zitieren

APA

Wang, Q., Yu, Y., Chang, Y., Xu, X., Wu, M., Ediriweera, G. R., Peng, H., Zhen, X., Jiang, X., Searles, D. J., Fu, C., & Whittaker, A. K. (2023). Fluoropolymer-MOF Hybrids with Switchable Hydrophilicity for 19 F MRI-Monitored Cancer Therapy. ACS Nano, 17(9), 8483-8498. https://doi.org/10.1021/acsnano.3c00694

Vancouver

Wang Q, Yu Y, Chang Y, Xu X, Wu M, Ediriweera GR, et al. Fluoropolymer-MOF Hybrids with Switchable Hydrophilicity for 19 F MRI-Monitored Cancer Therapy. ACS Nano. 2023;17(9):8483-8498. doi:10.1021/acsnano.3c00694

BibTeX
@article{Wang2023,
  author = {Wang, Qiaoyun and Yu, Ye and Chang, Yixin and Xu, Xin and Wu, Min and Ediriweera, Gayathri R and Peng, Hui and Zhen, Xu and Jiang, Xiqun and Searles, Debra J and Fu, Changkui and Whittaker, Andrew K},
  title = {Fluoropolymer-MOF Hybrids with Switchable Hydrophilicity for 19 F MRI-Monitored Cancer Therapy},
  journal = {ACS Nano},
  year = {2023},
  volume = {17},
  number = {9},
  pages = {8483--8498},
  doi = {10.1021/acsnano.3c00694}
}
Kostenlos starten →